Jeffrey Scott Behrens
Jeff Behrens is President and CEO of Siamab Therapeutics. He has worked in life sciences for the past 10 years at companies in the Boston area including Biogen, Alnylam, and Edimer Pharmaceuticals. Previously Jeff was founder and CEO of the Telluride Group, a Boston-based healthcare IT firm.
|MS||Biomedical Enterprise||MIT/Harvard Division of Health Sciences and Technology||2005-2007|
Fields of expertise